EUVIMEDEUVIMED entdecken
Editorial

Timeliness of Prostate Cancer Treatment in Medicare Advantage and Traditional Medicare: More Similarities than Differences?

Aaron P Mitchell iD, Nancy L Keating iD

JCO Oncology Practice · 22.06.2026

DOI: 10.1200/op-26-00534 ↗

Kurz gefasst

Editorial in der Zeitschrift JCO Oncology Practice, online erschienen am 22.06.2026. Verfasst von Aaron P Mitchell und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. Die Arbeit nennt 22 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Department of Health Care Policy, Harvard Medical School, Boston, MA.
  • Division of General Internal Medicine, Brigham and Women's Hospital, Boston MA.

ORCID-Profile: Aaron P Mitchell, Nancy L Keating

Zitieren

APA

Mitchell, A. P., & Keating, N. L. (2026). Timeliness of Prostate Cancer Treatment in Medicare Advantage and Traditional Medicare: More Similarities than Differences?. JCO Oncology Practice. https://doi.org/10.1200/op-26-00534

Vancouver

Mitchell AP, Keating NL. Timeliness of Prostate Cancer Treatment in Medicare Advantage and Traditional Medicare: More Similarities than Differences?. JCO Oncology Practice. 2026. doi:10.1200/op-26-00534

BibTeX
@article{Mitchell2026,
  author = {Mitchell, Aaron P and Keating, Nancy L},
  title = {Timeliness of Prostate Cancer Treatment in Medicare Advantage and Traditional Medicare: More Similarities than Differences?},
  journal = {JCO Oncology Practice},
  year = {2026},
  doi = {10.1200/op-26-00534}
}
Kostenlos starten →